Markers of Bone Disease in Children on Parenteral Nutrition

July 26, 2013 updated by: Glenda Courtney-Martin, The Hospital for Sick Children

Markers of Parenteral Nutrition (PN) Associated Metabolic Bone Disease in Children on Long-Term PN for Intestinal Failure.

Parenteral nutrition (PN) is the provision of nutrients via the intravenous route. Parenteral nutrition associated metabolic bone disease (MBD) was first described in children in the 1980s. Since then, there has been little to no research into the underlying relationship and as a result, little evidence on which to base clinical care. In adults, MBD is associated with increased fractures. At the Hospital for Sick children in Toronto, an intestinal failure program has been set up since 2003. This is the only intestinal failure program in Canada and receives country wide referrals. Most of the patients have short bowel syndrome (SBS) and require PN for prolonged periods, or for life. About 90% of these patients have MBD, and some have had bone fractures. An understanding of the etiology of MBD would provide information to guide care, and prevent this condition. Funding for this area of research however is challenging because intestinal failure requiring long term PN is a rare condition, accounting for approximately 200 - 300 children in all of Canada. The goal of this study therefore is to gather pilot data on markers of MBD in children on long term PN, and to compare these markers to age and gender matched control patients who are fed by mouth or feeding tube. The information gathered from this study will help us begin to understand what is actually happening in the bones of children on long term PN and will form the basis for future studies and improved clinical care.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, MG 1X8
        • The Hospital for Sick Children

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children on long term PN and childen not on PN.

Description

INCLUSION CRITERIA:

For Cases on Long-term PN:

  1. On PN for ≥ 6 consecutive weeks
  2. Willingness to participate in the study

For Control Subjects:

  1. Healthy as assessed by history and physical exam.
  2. Growing normally
  3. Are not on medications known to affect bone metabolism eg. Corticosteroids.
  4. Never received PN in the past

EXCLUSION CRITERIA:

For Cases on Long-term PN

  1. Patients who are on PN for shorter than 6 weeks
  2. Patients on hemodialysis

For Control Subjects

  1. Subjects who are not able to be matched to a case/subject on long-term PN for age and gender
  2. Positive history of fractures
  3. Subjects who are unable to participate because of fear of giving blood or unable to come to the hospital for sick children for blood draws.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Subjects on Parenteral Nutrition
cases are those on Parenteral Nutrition >6 weeks for intestinal failure.
Subjects not on Parenteral Nutrion
Controls are those who have never been on PN but can be fed via a feeding tube

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
serum osteocalcin
Time Frame: Over 8 months
Over 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Glenda Courtney-Martin, The Hospital for Sick Children

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (ACTUAL)

September 1, 2012

Study Completion (ACTUAL)

October 1, 2012

Study Registration Dates

First Submitted

May 18, 2012

First Submitted That Met QC Criteria

May 21, 2012

First Posted (ESTIMATE)

May 22, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

July 29, 2013

Last Update Submitted That Met QC Criteria

July 26, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Bone Disease

Subscribe